Gray Foundation
EndowmentCIK
2011602
Location
Cohoes, NY
Portfolio Value
Micro
$8,582,586
Diversification
Highly concentrated
Filing Date
Global Rank
#3,736
/ 8,586
▲ 218
Top Industry
Lodging
87.9%
3Y Alpha vs SPY
+4.8%
Period ended 3 months ago
Filed Apr 22, 2026 · 55d
10 quarters · since Dec 2023
Clone Performance
Feb 2024–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+70.5%
SPY
+55.8%
Annualised alpha
+4.8%
Max drawdown
−24.5%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
6 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
87.9%
+0.4 pts
Top 5
98.6%
−1.4 pts
Top 10
100.0%
0.0 pts
HHI
7,759
Highly concentrated+64
Portfolio Trend
10 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Consumer Cyclical | 91.2% | $230,798,779 |
| Healthcare | 3.4% | $8,582,586 |
| Real Estate | 3.3% | $8,467,239 |
| Industrials | 2.1% | $5,254,392 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reducedNo qualifying positions this quarter.
New Positions
Positions the filer opened this quarter
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| AZN | Astrazeneca PLC | 18,268 | $3,602,814 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
2 positions ·
$8,582,586 total
· Healthcare only
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Held | 37,800 | $4,979,772 | 58.02% | |
| AZN |
Astrazeneca PLC
Healthcare
|
NEW | 18,268 | $3,602,814 | 41.98% |